Prevention of postpartum haemorrhage in patients with severe preeclampsia using carbetocin versus misoprostol
Background. Haemorrhage is a leading cause of maternal death worldwide, accounting for over 30% of maternal deaths in Africa and Asia. Postpartum bleeding was also 1.6 times higher in women with preeclampsia than in normotensive women.Ibrahim K.A.M., Saad A.S., Murad A.W.A., Mohamed M.A.A.
Objective. We aimed to prevent postpartum haemorrhage in patients with severe preeclampsia by using either carbetocin or misoprostol. The primary outcome was postpartum haemorrhage (blood loss of ≥ 500 ml) while our Secondary outcomes included use of other uterotonics, blood transfusion, maternal complications and maternal death.
Methods. This prospective, randomised study was done in Department of Obstetrics and Gynecology, Benha university hospital, Benha University. 60 pregnant women candidate for vaginal delivery with severe preeclampsia received either carbetocin or misoprostol after delivery of the baby.
Results. Carbetocin was superior to misoprostol with lower duration of third stage of labour (P=0.036), lower amount of blood loss (P=0.017) and lower incidence of PPH (P=0.03). There was no significant difference in the pre-delivery and the post-delivery haemoglobin concentration between the two groups with P=0.061. The need of additional uterotonics and blood transfusion was higher with misoprostol as compared to cabetocin with P=0.037 and 0.009, respectively. As regards side effects, misoprostol was associated with shivering and pyrexia in significantly high number of patients as compared to cabetocin while nausea, vomiting and headache were more associated with cabetocin.
Conclusions. Carbetocin was more effective than misoprostol when used in women with severe preeclampsia to prevent postpartum bleeding.
Keywords
carbetocin
misoprostol
pre-eclampsia
postpartum haemorrhage
References
1. Khan K.S., Wojdyla D., Say L., Gülmezoglu A.M., Van Look P.F. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006; 367(9516): 1066-74.
2. AbouZahr C. Global burden of maternal death and disability. Br. Med. Bull. 2003; 67: 1-11.
3. Sentilhes L., Gromez A., Clavier E., Resch B., Descamps P., Marpeau L. Long-term psychological impact of severe postpartum hemorrhage. Acta Obstet. Gynecol. Scand. 2011; 90(6): 615-20.
4. Fullerton G., Danielian P., Bhattacharya S. Outcomes of pregnancy following postpartum haemorrhage. BJOG. 2013; 120(5): 621-7.
5. Cunningham F.G., Levono K.J., Bloom S.T., Hauth J.C., Rouse D.J., Spong C.Y. Williams obstetrics. 23rd ed. New York, NY: McGraw-Hill; 2010: 706-56.
6. Roberts J.M., Cooper D.W. Pathogenesis and genetics of preeclampsia. Lancet. 2001; 357(9249): 53-6.
7. Eskild A., Vatten L.J. Abnormal bleeding associated with preeclampsia: a population study of 315,085 pregnancies. Acta Obstet. Gynecol. Scand. 2009; 88(2): 154-8.
8. Pagel C., Lewychka S., Colbourn T., Mwansambo C., Meguid T., Chiudzu G. et al. Estimation of potential effects of improved community-based drug provision to augment health-facility strengthening, on maternal mortality due to post-partum haemorrhage and sepsis in sub-Saharan Africa: an equity-effectiveness model. Lancet. 2009; 374(9699): 1441-8.
9. Mobeen N., Durocher J., Zuberi N., Jahan N., Blum J., Wasim S. et al. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomized placebo-controlled trial. BJOG. 2011; 118(3): 353-61.
10. Norström A., Andersson A., Vilhardt H. Contractile effect of oxytocin and Ideamino- l-carba-2-tyrosine (O-methyl)-oxytocin in myometrial tissue from non-pregnant and term pregnant women. Acta Endocrinol. (Copenh) 1990; 122(5): 566-8.
11. Sweeney G., Holbrook A.M., Levine M., Yip M., Alfredson K., Cappi S. et al. Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, in nonpregnant women. Curr. Ther. Res. 1990; 47: 520-40.
12. Hunter D.J., Schulz P., Wassenaar W. Effect of carbetocin, a long-acting oxytocin analogue in the postpartum uterus. Clin. Pharmacol. Ther. 1992; 52(1): 60-7.
13. Van Dongen P.W., Verbruggen M.M., de Groot A.N.J.A., van Roosmalen J., Sporken J.M.J., Schulz M. Ascending dose tolerance study of intramuscular carbetocin administered after normal vaginal birth. Eur. J. Obstet. Gynecol. Reprod. Biol. 1998; 77(2): 181-7.
14. Boucher M., Nimrod C.A., Tawagi G.F., Meeker T.A., Rennicks White R.E., Vann J. Comparison of carbetocin and oxytocin for the prevention of postpartum haemorrhage following vaginal delivery: a double-blind randomized trial. J. Obstet. Gynaecol. Can. 2004; 26(5): 481-8.
15. Attilakos G., Psaroudakis D., Ash J., Buchanan R., Winter C., Donald F. et al. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial. BJOG. 2010; 117(8): 929-36.
16. Nirmala K., Zainuddin A.A., Ghani N.A., Zulkifli S., Jamil M.A. Carbetocin versus syntometrine in prevention of post-partum hemorrhage following vaginal delivery. J. Obstet. Gynaecol. Res. 2009; 35(1): 48-54.
17. Boucher M., Horbay G.L., Griffin P., Deschamps Y., Desjardins C., Schulz M. et al. Double-blind randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section. J. Perinatol. 1998; 18(3): 202-7.
18. Borruto F., Treisser A., Comparetto C. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial. Arch. Gynecol. Obstet. 2009; 280(5): 707-12.
Received 19.01.2017
Accepted 17.02.2017
About the Authors
Khalid abd Aziz Mohamad Ibrahim, MD, Lecturer of obstetrics and gynecology, Benha faculty of medicine and Benha university hospital, Benha University.Egypt, El Qulyobia governorate, Benha city, El Sadat Street. E-mail: dr.khalidkhader77@yahoo.com
Ahmed Samy Saad, MD, Lecturer of obstetrics and gynecology, Benha faculty of medicine and Benha university hospital, Benha University. Egypt, El Qulyobia governorate, Benha city, El Sadat Street. E-mail: drahmedsaad@live.com
Ahmed Walid Anwar Murad, MD, Assistant professor of obstetrics and gynecology, Benha faculty of medicine and Benha university hospital, Benha University.
Egypt, El Qulyobia governorate, Benha city, El Sadat Street. E-mail: awalid217@yahoo.com
Mohamed Abdel Ahdi Mohamed, MD, Assistant professor of obstetrics and gynecology, Benha faculty of medicine and Benha university hospital, Benha University.
Egypt, El Qulyobia governorate, Benha city, El Sadat Street. E-mail: drmafarag@yahoo.com
For citations: Ibrahim K.A.M., Saad A.S., Murad A.W.A., Mohamed M.A.A. Prevention of postpartum haemorrhage in patients with severe preeclampsia using carbetocin versus misoprostol. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2017; (9): 102-12. (in Russian)
http://dx.doi.org/10.18565/aig.2017.9.102-12
Similar Articles
